{"id":337,"date":"2017-09-15T09:04:55","date_gmt":"2017-09-15T14:04:55","guid":{"rendered":"\/?p=337"},"modified":"2018-02-02T07:53:27","modified_gmt":"2018-02-02T13:53:27","slug":"veterinary-oncology-market-profiled-new-report-brakke-consulting","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/ja\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","title":{"rendered":"Brakke Consulting\u306e\u65b0\u3057\u3044\u30ec\u30dd\u30fc\u30c8\u3067\u7363\u533b\u816b\u760d\u5b66\u5e02\u5834\u306e\u6982\u8981\u304c\u7d39\u4ecb\u3055\u308c\u3066\u3044\u307e\u3059"},"content":{"rendered":"<p><em>9\/15\/2017<\/em><\/p>\n<p>Brakke Consulting \u306e\u65b0\u3057\u3044\u7814\u7a76\u3067\u306f\u3001\u72ac\u3084\u732b\u306e\u6b7b\u56e0\u3067\u3042\u308b #1 \u3067\u3042\u308b\u764c\u306b\u3064\u3044\u3066\u8abf\u67fb\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u300c\u816b\u760d\u5b66\u306f\u3001\u73fe\u5728\u3001\u7363\u533b\u5b66\u3067\u6700\u3082\u95a2\u5fc3\u306e\u9ad8\u3044\u5206\u91ce\u306e\u4e00\u3064\u3067\u3059\u300d\u3068\u3001\u30d6\u30e9\u30c3\u30b1\u30fb\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u306e\u4e0a\u7d1a\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8\u3001\u30ea\u30f3\u30fb\u30d5\u30a9\u30f3\u30c9\u30f3\u7363\u533b\u5e2b\u306f\u8a9e\u308b\u3002\u300c\u904e\u53bb10\u5e74\u9593\u3067\u3001\u7c73\u56fd\u3067\u306f\u7363\u533b\u5b66\u3067\u627f\u8a8d\u3055\u308c\u305f\u764c\u6cbb\u7642\u6cd5\u304c\u30bc\u30ed\u304b\u30896\u7a2e\u985e\u4ee5\u4e0a\u306b\u5897\u3048\u3001\u3055\u3089\u306b\u6570\u5341\u7a2e\u985e\u304c\u958b\u767a\u4e2d\u3067\u3059\u3002\u300d<\/p>\n<p>\u72ac\u3068\u732b\u306e\u764c\u306b\u95a2\u3059\u308b\u7814\u7a76\u3067\u306f\u3001\u30da\u30c3\u30c8\u306e\u764c\u306e\u767a\u751f\u7387\u306b\u95a2\u3059\u308b\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u3001\u7363\u533b\u5b66\u306b\u304a\u3051\u308b\u764c\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u65b9\u6cd5\u3092\u8abf\u3079\u3001\u6cbb\u7642\u306b\u304b\u304b\u308b\u8cbb\u7528\u306e\u898b\u7a4d\u3082\u308a\u3092\u63d0\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u73fe\u5728\u5e02\u5834\u306b\u51fa\u56de\u3063\u3066\u3044\u308b FDA \u627f\u8a8d\u306e\u764c\u6cbb\u7642\u306b\u3064\u3044\u3066\u691c\u8a0e\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u6cbb\u7642\u6cd5\u3001\u8a3a\u65ad\u6cd5\u3001\u652f\u6301\u7642\u6cd5\u306a\u3069\u3001\u7363\u533b\u306e\u764c\u6cbb\u7642\u306e\u65b0\u88fd\u54c1\u3084\u958b\u767a\u4e2d\u306e\u88fd\u54c1\u3082\u30ec\u30dd\u30fc\u30c8\u306b\u8a18\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u7363\u533b\u627f\u8a8d\u306e\u764c\u6cbb\u7642\u306e\u73fe\u5728\u306e\u58f2\u4e0a\u3092\u63a8\u5b9a\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u5316\u5b66\u7642\u6cd5\u3084\u514d\u75ab\u7642\u6cd5\u3092\u53d7\u3051\u305f\u30da\u30c3\u30c8\u306e\u7dcf\u6570\u3092\u63a8\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u300c\u3053\u306e\u8abf\u67fb\u3067\u306f\u7363\u533b\u5e2b\u3068\u30da\u30c3\u30c8\u306e\u98fc\u3044\u4e3b\u306e\u4e21\u65b9\u306b\u30a2\u30f3\u30b1\u30fc\u30c8\u3092\u5b9f\u65bd\u3057\u3001\u6570\u5343\u30c9\u30eb\u306b\u3082\u53ca\u3076\u8cbb\u7528\u304c\u304b\u304b\u308b\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u3001\u591a\u304f\u306e\u72ac\u3084\u732b\u306e\u98fc\u3044\u4e3b\u304c\u30da\u30c3\u30c8\u304c\u764c\u3068\u8a3a\u65ad\u3055\u308c\u305f\u5834\u5408\u306b\u306f\u6cbb\u7642\u3092\u53d7\u3051\u308b\u610f\u601d\u304c\u3042\u308b\u3053\u3068\u304c\u5206\u304b\u308a\u307e\u3057\u305f\u300d\u3068\u30d5\u30a9\u30f3\u30c9\u30f3\u535a\u58eb\u306f\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u308b\u3002<\/p>\n<p>\u3053\u306e\u5831\u544a\u66f8\u306f\u30012002\u5e74\u306b\u521d\u3081\u3066\u5b9f\u65bd\u3055\u308c\u3001\u305d\u306e\u5f8c2009\u5e74\u30682014\u5e74\u306b\u66f4\u65b0\u3055\u308c\u305f\u8abf\u67fb\u306e\u7b2c4\u7248\u3067\u3042\u308a\u3001\u51fa\u7248\u3055\u308c\u305f\u6587\u732e\u3001\u5c02\u9580\u5bb6\u3078\u306e\u30a4\u30f3\u30bf\u30d3\u30e5\u30fc\u3001350\u4eba\u4ee5\u4e0a\u306e\u5c0f\u52d5\u7269\u7363\u533b\u5e2b\u3068500\u4eba\u4ee5\u4e0a\u306e\u30da\u30c3\u30c8\u306e\u98fc\u3044\u4e3b\u3078\u306e\u8abf\u67fb\u306a\u3069\u3001\u3055\u307e\u3056\u307e\u306a\u60c5\u5831\u6e90\u304b\u3089\u60c5\u5831\u3092\u53ce\u96c6\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u300e\u72ac\u3068\u732b\u306e\u764c\u300f\u306f\u3001Brakke Consulting \u304b\u3089 $7,500 \u3067\u8cfc\u5165\u3067\u304d\u307e\u3059\u3002\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001Brakke Consulting \u306e Web \u30b5\u30a4\u30c8 (www.BrakkeConsulting.com) \u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>Brakke Consulting\u306b\u3064\u3044\u3066<\/strong><\/p>\n<p>Brakke Consulting \u306f 30 \u5e74\u306b\u308f\u305f\u308a\u3001\u5e02\u5834\u8abf\u67fb\u3001\u65b0\u898f\u4e8b\u696d\u958b\u767a\u3001\u88fd\u54c1\u8a55\u4fa1\u3001\u6d41\u901a\u6226\u7565\u306a\u3069\u3001\u52d5\u7269\u533b\u7642\u696d\u754c\u5411\u3051\u306e\u5305\u62ec\u7684\u306a\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u3066\u304d\u307e\u3057\u305f\u3002\u540c\u793e\u306f\u30b7\u30f3\u30b8\u30b1\u30fc\u30c8\u5e02\u5834\u8abf\u67fb\u3067\u77e5\u3089\u308c\u3001\u696d\u754c\u306b\u6226\u7565\u7684\u3067\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>###<\/p>\n<p><a href=\"\/wp-content\/uploads\/2018\/01\/9-15-17_CancerStudy_NR.pdf\" target=\"_blank\" rel=\"noopener\">\u30d7\u30ea\u30f3\u30bf\u5bfe\u5fdc<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>2017\u5e749\u670815\u65e5\u3001Brakke Consulting\u793e\u306e\u65b0\u305f\u306a\u7814\u7a76\u306f\u3001\u72ac\u3084\u732b\u306e\u547d\u53d6\u308a\u3068\u306a\u308b#1\u907a\u4f1d\u5b50\u306e\u5909\u7570\u4f53\u3001\u3059\u306a\u308f\u3061\u304c\u3093\u306b\u3064\u3044\u3066\u8003\u5bdf\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u816b\u760d\u5b66\u306f\u3001\u4eca\u65e5\u306e\u7363\u533b\u5b66\u306b\u304a\u3044\u3066\u6700\u3082\u95a2\u5fc3\u306e\u9ad8\u3044\u5206\u91ce\u306e\u4e00\u3064\u3067\u3059\u300d\u3068\u3001Brakke Consulting\u793e\u306e\u30b7\u30cb\u30a2\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8\u3067\u3042\u308b\u30ea\u30f3\u30fb\u30d5\u30a9\u30f3\u30c9\u30f3\u7363\u533b\u5e2b\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u904e\u53bb10\u5e74\u9593\u3067\u3001\u7c73\u56fd\u3067\u306f\u7363\u533b\u5b66\u3067\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u304c\u3093\u6cbb\u7642\u6cd5\u304c\u30bc\u30ed\u304b\u30896\u7a2e\u985e\u4ee5\u4e0a\u306b\u5897\u52a0\u3057\u3001\u3055\u3089\u306b\u6570\u5341\u7a2e\u985e\u304c\u958b\u767a\u4e2d\u3067\u3059\u3002\u300d\u3053\u306e\u7814\u7a76\u300c\u72ac\u3068\u732b\u306e\u304c\u3093\u300d\u3067\u306f\u3001\u30da\u30c3\u30c8\u306e\u304c\u3093\u767a\u75c7\u7387\u306b\u95a2\u3059\u308b\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u3001\u7363\u533b\u5b66\u306b\u304a\u3051\u308b\u304c\u3093\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u65b9\u6cd5\u306e\u691c\u8a3c\u3001\u305d\u3057\u3066\u6cbb\u7642\u8cbb\u306e\u63a8\u5b9a\u5024\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5831\u544a\u66f8\u3067\u306f\u3001\u73fe\u5728\u5e02\u8ca9\u3055\u308c\u3066\u3044\u308bFDA\u627f\u8a8d\u306e\u304c\u3093\u6cbb\u7642\u6cd5\u3092\u30ec\u30d3\u30e5\u30fc\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u6cbb\u7642\u6cd5\u3001\u8a3a\u65ad\u6cd5\u3001\u652f\u6301\u7642\u6cd5\u306a\u3069\u3001\u65b0\u898f\u304a\u3088\u3073\u958b\u767a\u4e2d\u306e\u7363\u533b\u7528\u304c\u3093\u6cbb\u7642\u85ac\u306b\u3064\u3044\u3066\u3082\u7d39\u4ecb\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5831\u544a\u66f8\u306f\u3001\u7363\u533b\u5e2b\u304c\u627f\u8a8d\u3057\u305f\u304c\u3093\u6cbb\u7642\u85ac\u306e\u73fe\u5728\u306e\u58f2\u4e0a\u3092\u63a8\u5b9a\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u5316\u5b66\u7642\u6cd5\u307e\u305f\u306f\u514d\u75ab\u7642\u6cd5\u3092\u53d7\u3051\u305f\u30da\u30c3\u30c8\u306e\u7dcf\u6570\u306e\u63a8\u5b9a\u5024\u3082\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u3053\u306e\u8abf\u67fb\u3067\u306f\u7363\u533b\u5e2b\u3068\u98fc\u3044\u4e3b\u306e\u4e21\u65b9\u306b\u8abf\u67fb\u3092\u5b9f\u65bd\u3057\u3001\u6570\u5343\u30c9\u30eb\u306b\u3082\u53ca\u3076\u8cbb\u7528\u304c\u304b\u304b\u308b\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u3001\u591a\u304f\u306e\u72ac\u3084\u732b\u306e\u98fc\u3044\u4e3b\u304c\u30da\u30c3\u30c8\u304c\u304c\u3093\u3068\u8a3a\u65ad\u3055\u308c\u305f\u969b\u306b\u6cbb\u7642\u3092\u53d7\u3051\u308b\u610f\u601d\u304c\u3042\u308b\u3053\u3068\u304c\u308f\u304b\u308a\u307e\u3057\u305f\u300d\u3068\u30d5\u30a9\u30f3\u30c9\u30f3\u535a\u58eb\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5831\u544a\u66f8\u306f\u30012002\u5e74\u306b\u521d\u3081\u3066\u5b9f\u65bd\u3055\u308c\u3001\u305d\u306e\u5f8c2009\u5e74\u30682014\u5e74\u306b\u6539\u8a02\u3055\u308c\u305f\u8abf\u67fb\u306e\u7b2c4\u7248\u3067\u3059\u3002<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\" class=\"view-full-post-btn\">\u5168\u6587\u3092\u898b\u308b<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"class_list":["post-337","post","type-post","status-publish","format-standard","hentry","category-company-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/ja\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"9\/15\/2017 A new study from Brakke Consulting offers a look into the #1 killer of dogs and cats: cancer. \u201dOncology is one of the highest interest areas in veterinary medicine today,\u201d said Lynn Fondon DVM, a senior consultant at Brakke Consulting. \u201cIn the past decade, the US has gone from zero cancer therapies approved for veterinary use to a more than a half-dozen, with dozens more in development.\u201d The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment. The report reviews the FDA-approved cancer treatments that are now on the market; new and developing veterinary cancer products, including therapies, diagnostics, and supportive care, are also presented in the report. The report estimates the current sales of veterinary-approved cancer therapies, as well as providing estimates of the total number of pets treated with chemotherapy or immunotherapy. \u201cWe surveyed both veterinarians and pet owners for this study, and we found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer,\u201d comments Dr. Fondon. The report &#8211; the fourth edition of a study first fielded in 2002, and subsequently updated in 2009 and 2014 &#8211;View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/ja\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-15T14:04:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-02T13:53:27+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Veterinary oncology market is profiled in new report from Brakke Consulting\",\"datePublished\":\"2017-09-15T14:04:55+00:00\",\"dateModified\":\"2018-02-02T13:53:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\"},\"wordCount\":321,\"articleSection\":[\"Company News\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\",\"url\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"datePublished\":\"2017-09-15T14:04:55+00:00\",\"dateModified\":\"2018-02-02T13:53:27+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veterinary oncology market is profiled in new report from Brakke Consulting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brakke Consulting\u304b\u3089\u306e\u30cb\u30e5\u30fc\u30b9","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/ja\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","og_locale":"ja_JP","og_type":"article","og_title":"News from Brakke Consulting","og_description":"9\/15\/2017 A new study from Brakke Consulting offers a look into the #1 killer of dogs and cats: cancer. \u201dOncology is one of the highest interest areas in veterinary medicine today,\u201d said Lynn Fondon DVM, a senior consultant at Brakke Consulting. \u201cIn the past decade, the US has gone from zero cancer therapies approved for veterinary use to a more than a half-dozen, with dozens more in development.\u201d The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment. The report reviews the FDA-approved cancer treatments that are now on the market; new and developing veterinary cancer products, including therapies, diagnostics, and supportive care, are also presented in the report. The report estimates the current sales of veterinary-approved cancer therapies, as well as providing estimates of the total number of pets treated with chemotherapy or immunotherapy. \u201cWe surveyed both veterinarians and pet owners for this study, and we found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer,\u201d comments Dr. Fondon. The report &#8211; the fourth edition of a study first fielded in 2002, and subsequently updated in 2009 and 2014 &#8211;View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/ja\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","og_site_name":"Brakke Consulting Website","article_published_time":"2017-09-15T14:04:55+00:00","article_modified_time":"2018-02-02T13:53:27+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"Brakke Consulting","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Veterinary oncology market is profiled in new report from Brakke Consulting","datePublished":"2017-09-15T14:04:55+00:00","dateModified":"2018-02-02T13:53:27+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/"},"wordCount":321,"articleSection":["Company News"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","url":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","name":"Brakke Consulting\u304b\u3089\u306e\u30cb\u30e5\u30fc\u30b9","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"datePublished":"2017-09-15T14:04:55+00:00","dateModified":"2018-02-02T13:53:27+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Veterinary oncology market is profiled in new report from Brakke Consulting"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u30d6\u30e9\u30c3\u30b1\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0","url":"https:\/\/brakkeconsulting.com\/ja\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/posts\/337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/comments?post=337"}],"version-history":[{"count":2,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/posts\/337\/revisions"}],"predecessor-version":[{"id":11989,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/posts\/337\/revisions\/11989"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/media?parent=337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/categories?post=337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/tags?post=337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}